LobbyingHospice Action Network lobbying by quarter
Hospice Action Network's latest lobbying report covers Q4 2024, at $420K. Its first report covers Q4 2022; the issues it reports most are Medicare/Medicaid and Health Issues.
Hospice Action Network
- Latest quarter
- No record
- Q3 2026 · 0 reports
- Last 12 months
- $0
- Last 4 quarters
- vs last quarter
- No record
- Q3 2026 against the quarter before
- First report
- Q4 2022
- The first quarter a report named it
Lobbying by quarter
| Quarter | Amount | Reports |
|---|---|---|
| Q4 2022 | $370K | 4 |
| Q1 2023 | $380K | 4 |
| Q2 2023 | $400K | 5 |
| Q3 2023 | $380K | 5 |
| Q4 2023 | $390K | 5 |
| Q1 2024 | $340K | 3 |
| Q2 2024 | $340K | 3 |
| Q3 2024 | $400K | 4 |
| Q4 2024 | $420K | 4 |
| Q1 2025 | $0 | 0 |
| Q2 2025 | $0 | 0 |
| Q3 2025 | $0 | 0 |
| Q4 2025 | $0 | 0 |
| Q1 2026 | $0 | 0 |
| Q2 2026 | $0 | 0 |
| Q3 2026 | $0 | 0 |
By issue
- Medicare and Medicaid$1.4M · 32 reports
- Health issues$1.4M · 25 reports
- Veterans$456.7K · 11 reports
- Budget and appropriations$186.7K · 6 reports
An issue's amount splits each report's amount equally over the issues the report lists.
Who was lobbied
- HOUSE OF REPRESENTATIVES32 reports
- SENATE32 reports
- Health & Human Services, Dept of (HHS)16 reports
- Centers For Medicare and Medicaid Services (CMS)13 reports
- White House Office12 reports
- Office of Management & Budget (OMB)7 reports
- Food & Drug Administration (FDA)3 reports
- Drug Enforcement Administration (DEA)1 reports
- Medicare Payment Advisory Commission (MedPAC)1 reports
Firms it paid
| Firm | ||
|---|---|---|
| In-houseHospice Action Network | $2.5M | 9 quarters |
| The Nickles Group | $450K | 9 quarters |
| Penn Avenue Partners | $300K | 5 quarters |
| McDermott+ | $100K | 2 quarters |
| I Street Advocates | $70K | 7 quarters |
| Hogan Lovells Cadwalader US | $0 | 5 quarters |
Former officials lobbying for it
| Former position | ||
|---|---|---|
| DEBRA CURTIS | 1998-2013: Legislative Director, Chief of Staff, Rep. Pete Stark; jointly Professional Staff on Committee on Ways and Means, Health Subcommittee | Q4 2024 |
| LEIGH FELDMAN | 2016-2017: Senate Finance Committee (Detailee) | Q4 2024 |
| LOGAN MATTHEW HOOVER | Legislative Director, Rep. Tom Reed | Q4 2024 |
| RODNEY WHITLOCK | 2011-2015: Health Policy Director, Sen. Chuck Grassley; 2005-2010: Health Policy Advisor, Senate Finance Committee; 2003-2005: Legislative Director, Rep. Charlie Norwood; 1997-2002: Legislative Assistant, Rep. Charlie Norwood | Q4 2024 |
| JAY SULZMANN | Legislative Director/Health Policy Advisor, Sen. Johnny Isakson; Sr. Policy Advisor/LA/LC/SA, Rep. Wally Herger | Q4 2023 |
| TIMOTHY FARRELL HANNEGAN | U.S. General Accounting Office | Q4 2023 |
| CHRISTINA MCGARRY DAVID | Legislative Assistant / Scheduler, Rep. Mario Diaz-Balart; Intern, Rep. Doc Hastings | Q3 2023 |
Lobbying reports
| Filed by | ||
|---|---|---|
| 25/04/04for Q4 2024 | McDermott+ | $60K |
| 25/03/11for Q4 2024 | McDermott+ | $60K |
| 25/03/11for Q3 2024 | McDermott+ | $40K |
| 25/01/21for Q4 2024 | The Nickles Group | $50K |
| 25/01/15for Q4 2024 | McDermott+ | $60K |
| 25/01/14for Q4 2024 | In-house | $300K |
| 25/01/13for Q4 2024 | I Street Advocates | $10K |
| 25/01/13for Q4 2024 | I Street Advocates | $10K |
| 25/01/08for Q4 2024 | I Street Advocates | $10K |
| 24/10/21for Q3 2024 | The Nickles Group | $50K |
| 24/10/21for Q3 2024 | In-house | $300K |
| 24/10/17for Q3 2024 | McDermott+ | $40K |
| 24/10/14for Q3 2024 | I Street Advocates | $10K |
| 24/09/16for Q3 2024 | McDermott+ | Under $5,000 |
| 24/08/13for Q2 2024 | McDermott+ | Under $5,000 |
| 24/07/22for Q2 2024 | The Nickles Group | $50K |
| 24/07/20for Q2 2024 | In-house | $280K |
| 24/07/12for Q2 2024 | I Street Advocates | $10K |
| 24/04/22for Q1 2024 | The Nickles Group | $50K |
| 24/04/19for Q1 2024 | In-house | $280K |